Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China
· Delayed Price · Currency is CNY 33.22
-1.19 (-3.46%)
Feb 28, 2025, 2:45 PM CST
SHE:002653 Revenue
Haisco Pharmaceutical Group had revenue of 1.06B CNY in the quarter ending September 30, 2024, with 4.96% growth. This brings the company's revenue in the last twelve months to 3.72B, up 12.72% year-over-year. In the year 2023, Haisco Pharmaceutical Group had annual revenue of 3.36B with 11.27% growth.
Revenue (ttm)
3.72B
Revenue Growth
+12.72%
P/S Ratio
9.86
Revenue / Employee
683.25K
Employees
5,448
Market Cap
36.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.36B | 339.78M | 11.27% |
| Jan 1, 2023 | 3.02B | 241.98M | 8.73% |
| Jan 1, 2022 | 2.77B | -556.28M | -16.71% |
| Dec 31, 2020 | 3.33B | -607.74M | -15.44% |
| Dec 31, 2019 | 3.94B | 510.68M | 14.90% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Jan 1, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.93B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Sichuan Biokin Pharmaceutical | 5.85B |